Stock Comparison

BBIO vs REGN

BridgeBio Pharma Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

BBIO

BridgeBio Pharma Inc

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$15.87B

$80.55B

P/E (TTM)

—

19.4

Forward P/E

—

17.1

Price/Sales

27.4

5.2

Price/Book

118.6

2.5

EV/EBITDA

-9.0

13.1

Dividend Yield

—

0.45%

Profitability

Net Margin

-102.70%

29.65%

Operating Margin

-80.17%

24.32%

Return on Equity

-1790.00%

14.00%

Return on Assets

-28.00%

6.53%

Growth (YoY)

Revenue Growth

66.80%

16.70%

Earnings Growth

0.00%

-4.50%

Price & Risk

Beta

1.0

0.2

52-Week High

$90.17

$810.12

52-Week Low

$47.29

$553.38

Analyst Target

$106.19

$833.54

Compare BBIO and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.